KKR taking $400 mln dividend on Capsugel

Drug capsule maker Capsugel is refinancing $1 billion of leveraged loans in a deal that also finances a $400 million dividend payment to its private equity owner Kohlberg Kravis Roberts & Co, banking sources said.

15 July 2014•1 min read
Feature image
LinkedInXEmail
LinkedInXEmail